These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 877237)

  • 21. Fission fragment RBE for bone sarcoma induction.
    Mays CW; Lloyd RD; Taylor GN; Shabestari LR; Angus W; Atherton DR; Gillett NA
    Radiat Res; 1989 Sep; 119(3):432-42. PubMed ID: 2772136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More about comparing bone sarcoma induction in humans from 224Ra and 226Ra.
    Lloyd RD
    Health Phys; 1994 Aug; 67(2):198. PubMed ID: 8026977
    [No Abstract]   [Full Text] [Related]  

  • 23. Bone cancer from radium: canine dose response explains data for mice and humans.
    Raabe OG; Book SA; Parks NJ
    Science; 1980 Apr; 208(4439):61-4. PubMed ID: 7361106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of 226Ra on bone marrow stem cells in mice: effect of radium decorporation by a long-term treatment with Na-alginate on stem-cell damage.
    Schoeters G; Van Puymbroeck S; Vanderborght O
    Radiat Res; 1980 Apr; 82(1):74-80. PubMed ID: 7367590
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone sarcoma characteristics and distribution in beagles injected with radium-226.
    White RG; Raabe OG; Culbertson MR; Parks NJ; Samuels SJ; Rosenblatt LS
    Radiat Res; 1994 Mar; 137(3):361-70. PubMed ID: 8146280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments on the concepts of biophysical dose and dose rate in continuous irradiation.
    Momeni MH
    Health Phys; 1975 Mar; 28(3):307-8. PubMed ID: 1112734
    [No Abstract]   [Full Text] [Related]  

  • 27. Pulmonary distribution of alpha dose from 239PuO2 and induction of neoplasia in rats and dogs.
    Sanders CL; Park JF
    Inhaled Part; 1970; 1():489-98. PubMed ID: 5527721
    [No Abstract]   [Full Text] [Related]  

  • 28. The osteosarcomogenic efficiency of low 224radium-doses in mice compared to that of the short-lived beta-emitting rare earth 177lutetium.
    Müller WA; Luz A; Schäffer EH
    Strahlentherapie Sonderb; 1985; 80():79-82. PubMed ID: 4095741
    [No Abstract]   [Full Text] [Related]  

  • 29. The skeletal dose from 224Ra following intravascular administration of thorotrast.
    Rowland RE; Rundo J
    RISO Rep; 1973 Jun; (294):95-103. PubMed ID: 4549676
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of alpha-particle irradiation on carcinogenesis.
    Stather JW
    Int J Radiat Biol; 1990 Nov; 58(5):871-4. PubMed ID: 1977832
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of age at time of exposure to 226Ra or 239Pu on distribution, retention, postinjection survival, and tumor induction in beagle dogs.
    Bruenger FW; Lloyd RD; Miller SC
    Radiat Res; 1991 Mar; 125(3):248-56. PubMed ID: 2000447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-induced systemic and local bone tumors: two types of late effects with possible different origins?
    Müller WA; Luz A; Linzner U
    Radiat Res; 1994 Jun; 138(3):415-22. PubMed ID: 8184017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The question of safe radiation thresholds for alpha emitting bone seekers in man.
    Gofman JW; Tamplin AR
    Health Phys; 1971 Jul; 21(1):47-51. PubMed ID: 5286554
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationships between cell survival and specific energy spectra for therapeutic alpha-particle emitters.
    Roeske JC; Stinchcomb TG
    Radiat Res; 1996 Mar; 145(3):268-73. PubMed ID: 8927693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone cancer risk of (239)pu in humans derived from animal models.
    Bijwaard H; Dekkers F
    Radiat Res; 2007 Nov; 168(5):582-92. PubMed ID: 17973546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual radiation action and the initial slope of survival curves.
    Zaider M; Rossi HH
    Radiat Res Suppl; 1985; 8():S68-76. PubMed ID: 3867091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the carcinogenicity of radium and bone-seeking actinides.
    Raabe OG
    Health Phys; 1984 Jun; 46(6):1241-58. PubMed ID: 6327574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing bone sarcoma induction in humans from 224Ra and 226+228Ra.
    Lloyd RD
    Health Phys; 1993 Nov; 65(5):560-1. PubMed ID: 8225998
    [No Abstract]   [Full Text] [Related]  

  • 39. Logistic estimate of the final incidence of late radiation effects.
    Sedlák A
    Health Phys; 1986 Sep; 51(3):357-64. PubMed ID: 3744837
    [No Abstract]   [Full Text] [Related]  

  • 40. Does the growth rate of a radionuclide-induced osteosarcoma depend on the skeletal dose rate during the growth period?
    Lloyd RD
    Health Phys; 1990 Jan; 58(1):73-6. PubMed ID: 2294077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.